Cargando…
The G2 checkpoint—a node‐based molecular switch
Tight regulation of the eukaryotic cell cycle is paramount to ensure genomic integrity throughout life. Cell cycle checkpoints are present in each phase of the cell cycle and prevent cell cycle progression when genomic integrity is compromised. The G2 checkpoint is an intricate signaling network tha...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377395/ https://www.ncbi.nlm.nih.gov/pubmed/28396830 http://dx.doi.org/10.1002/2211-5463.12206 |
_version_ | 1782519308741509120 |
---|---|
author | de Gooijer, Mark C. van den Top, Arnout Bockaj, Irena Beijnen, Jos H. Würdinger, Thomas van Tellingen, Olaf |
author_facet | de Gooijer, Mark C. van den Top, Arnout Bockaj, Irena Beijnen, Jos H. Würdinger, Thomas van Tellingen, Olaf |
author_sort | de Gooijer, Mark C. |
collection | PubMed |
description | Tight regulation of the eukaryotic cell cycle is paramount to ensure genomic integrity throughout life. Cell cycle checkpoints are present in each phase of the cell cycle and prevent cell cycle progression when genomic integrity is compromised. The G2 checkpoint is an intricate signaling network that regulates the progression of G2 to mitosis (M). We propose here a node‐based model of G2 checkpoint regulation, in which the action of the central CDK1–cyclin B1 node is determined by the concerted but opposing activities of the Wee1 and cell division control protein 25C (CDC25C) nodes. Phosphorylation of both Wee1 and CDC25C at specific sites determines their subcellular localization, driving them either toward activity within the nucleus or to the cytoplasm and subsequent ubiquitin‐mediated proteasomal degradation. In turn, this subcellular balance of the Wee1 and CDC25C nodes is directed by the action of the PLK1 and CHK1 nodes via what we have termed the ‘nuclear and cytoplasmic decision states’ of Wee1 and CDC25C. The proposed node‐based model provides an intelligible structure of the complex interactions that govern the decision to delay or continue G2/M progression. The model may also aid in predicting the effects of agents that target these G2 checkpoint nodes. |
format | Online Article Text |
id | pubmed-5377395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53773952017-04-10 The G2 checkpoint—a node‐based molecular switch de Gooijer, Mark C. van den Top, Arnout Bockaj, Irena Beijnen, Jos H. Würdinger, Thomas van Tellingen, Olaf FEBS Open Bio Hypothesis Tight regulation of the eukaryotic cell cycle is paramount to ensure genomic integrity throughout life. Cell cycle checkpoints are present in each phase of the cell cycle and prevent cell cycle progression when genomic integrity is compromised. The G2 checkpoint is an intricate signaling network that regulates the progression of G2 to mitosis (M). We propose here a node‐based model of G2 checkpoint regulation, in which the action of the central CDK1–cyclin B1 node is determined by the concerted but opposing activities of the Wee1 and cell division control protein 25C (CDC25C) nodes. Phosphorylation of both Wee1 and CDC25C at specific sites determines their subcellular localization, driving them either toward activity within the nucleus or to the cytoplasm and subsequent ubiquitin‐mediated proteasomal degradation. In turn, this subcellular balance of the Wee1 and CDC25C nodes is directed by the action of the PLK1 and CHK1 nodes via what we have termed the ‘nuclear and cytoplasmic decision states’ of Wee1 and CDC25C. The proposed node‐based model provides an intelligible structure of the complex interactions that govern the decision to delay or continue G2/M progression. The model may also aid in predicting the effects of agents that target these G2 checkpoint nodes. John Wiley and Sons Inc. 2017-03-04 /pmc/articles/PMC5377395/ /pubmed/28396830 http://dx.doi.org/10.1002/2211-5463.12206 Text en © 2017 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Hypothesis de Gooijer, Mark C. van den Top, Arnout Bockaj, Irena Beijnen, Jos H. Würdinger, Thomas van Tellingen, Olaf The G2 checkpoint—a node‐based molecular switch |
title | The G2 checkpoint—a node‐based molecular switch |
title_full | The G2 checkpoint—a node‐based molecular switch |
title_fullStr | The G2 checkpoint—a node‐based molecular switch |
title_full_unstemmed | The G2 checkpoint—a node‐based molecular switch |
title_short | The G2 checkpoint—a node‐based molecular switch |
title_sort | g2 checkpoint—a node‐based molecular switch |
topic | Hypothesis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377395/ https://www.ncbi.nlm.nih.gov/pubmed/28396830 http://dx.doi.org/10.1002/2211-5463.12206 |
work_keys_str_mv | AT degooijermarkc theg2checkpointanodebasedmolecularswitch AT vandentoparnout theg2checkpointanodebasedmolecularswitch AT bockajirena theg2checkpointanodebasedmolecularswitch AT beijnenjosh theg2checkpointanodebasedmolecularswitch AT wurdingerthomas theg2checkpointanodebasedmolecularswitch AT vantellingenolaf theg2checkpointanodebasedmolecularswitch AT degooijermarkc g2checkpointanodebasedmolecularswitch AT vandentoparnout g2checkpointanodebasedmolecularswitch AT bockajirena g2checkpointanodebasedmolecularswitch AT beijnenjosh g2checkpointanodebasedmolecularswitch AT wurdingerthomas g2checkpointanodebasedmolecularswitch AT vantellingenolaf g2checkpointanodebasedmolecularswitch |